Mammary Paget Disease is Not an Independent Prognostic Factor: A Contemporary SEER Analysis
The American Surgeon™ · 2026-12 · 92 (12) · 3201-3212
DOI: 10.1177/00031348261457571 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Surgeon™, online erschienen am 11.06.2026. Verfasst von Bilal Turan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey. Hauptthemen laut MEDLINE: Paget's Disease, Mammary, Breast Neoplasms. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Purpose
This study aimed to provide an updated evaluation of the clinicopathological characteristics and survival outcomes of mammary Paget disease by analyzing pure Paget, Paget + DCIS, and Paget + IDC subgroups within the contemporary SEER cohort, which includes consistent HER2 reporting and reflects the modern systemic therapy era.
Methods
Cases diagnosed in the SEER database between 2010 and 2021 were analyzed. Clinicopathological parameters were compared across subgroups. Overall survival (OS) and cancer-specific survival (CSS) were evaluated using Kaplan-Meier analyses and multivariable Cox regression models.
Results
Paget-associated subgroups exhibited distinct biological profiles, characterized by lower hormone receptor positivity and markedly higher HER2 positivity compared with IDC. In unadjusted analyses, pure Paget and Paget + IDC groups demonstrated lower survival, whereas Paget + DCIS showed the most favorable outcomes (P < 0.001) . However, after adjustment for key prognostic determinants, including age, stage, grade, nodal status, and treatment, histological subgroup was not an independent predictor of OS or CSS.
Conclusion
In the modern therapeutic era, survival differences across the Paget spectrum appear to reflect the underlying carcinoma’s biological and clinical characteristics rather than the presence of Paget disease itself. This study represents the most contemporary, comprehensively adjusted population-level analysis to date and clarifies that, when tumors are matched for stage and subtype, Paget disease does not independently worsen prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
- Department of General Surgery, Abdulkadir Yuksel State Hospital, Gaziantep, Turkey.
- Department of General Surgery, Bagcilar Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
- Department of Radiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey.
ORCID-Profile: Bilal Turan, Ahmet Necati Sanli, Ali Karabulut
Zitieren
APA
Turan, B., Sanli, A. N., Karabulut, A., & Tekcan Sanli, D. E. (2026). Mammary Paget Disease is Not an Independent Prognostic Factor: A Contemporary SEER Analysis. The American Surgeon™, 92(12), 3201-3212. https://doi.org/10.1177/00031348261457571
Vancouver
Turan B, Sanli AN, Karabulut A, Tekcan Sanli DE. Mammary Paget Disease is Not an Independent Prognostic Factor: A Contemporary SEER Analysis. The American Surgeon™. 2026;92(12):3201-3212. doi:10.1177/00031348261457571
BibTeX
@article{Turan2026,
author = {Turan, Bilal and Sanli, Ahmet Necati and Karabulut, Ali and Tekcan Sanli, Deniz Esin},
title = {Mammary Paget Disease is Not an Independent Prognostic Factor: A Contemporary SEER Analysis},
journal = {The American Surgeon™},
year = {2026},
volume = {92},
number = {12},
pages = {3201--3212},
doi = {10.1177/00031348261457571}
}
EUVIMED